We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International ConventionJune 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag TechJuly 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
February 11 - 12, 2019 | New York, New York
Noël Brown is a Managing Director in the Healthcare Investment Banking Group at Cantor Fitzgerald where he advises biopharmaceutical companies on equity and debt capital markets, initial public offerings, mergers and acquisitions and cross-border transactions. He has advised on more than $15 billion of transactions over more than 20 years in the securities industry, including one of the largest biotech initial public offering in history.
Prior to joining Cantor, Mr. Brown was a Managing Director in the Healthcare investment banking groups of RBC Capital Markets and Piper Jaffray and a Director at Lehman Brothers/Barclays Capital. He currently serves on the National Board of Trustees of the Crohn's & Colitis Foundation, the Healthcare Advisory Board of the Partnership Fund for New York City, and the MIT Sloan School of Business Alumni Board. Mr. Brown received his MBA with a concentration in Financial Management from the MIT Sloan School of Business where he was a Sherburne Fellow, his LL.B. from the University of Ottawa Faculty of Law, and his B.A. from the University of Western Ontario.
This speaker's sessions: